Here is What Hedge Funds Think About Qiagen NV (QGEN)

Hedge funds run by legendary names like George Soros and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to have a minimum of $1 million liquid to invest in a hedge fund) by spending enormous resources on analyzing and uncovering data about small-cap stocks that the big brokerage houses don’t follow. Small caps are where they can generate significant outperformance. That’s why we pay special attention to hedge fund activity in these stocks.

Is Qiagen NV (NASDAQ:QGEN) a bargain? Prominent investors are turning less bullish. The number of bullish hedge fund bets were trimmed by 3 lately. Our calculations also showed that QGEN isn’t among the 30 most popular stocks among hedge funds. QGEN was in 21 hedge funds’ portfolios at the end of December. There were 24 hedge funds in our database with QGEN positions at the end of the previous quarter.

In today’s marketplace there are several gauges market participants put to use to assess their stock investments. Two of the best gauges are hedge fund and insider trading activity. Our researchers have shown that, historically, those who follow the best picks of the best fund managers can outclass the broader indices by a solid amount (see the details here).


We’re going to review the new hedge fund action regarding Qiagen NV (NASDAQ:QGEN).

How are hedge funds trading Qiagen NV (NASDAQ:QGEN)?

At the end of the fourth quarter, a total of 21 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of -13% from one quarter earlier. On the other hand, there were a total of 26 hedge funds with a bullish position in QGEN a year ago. So, let’s review which hedge funds were among the top holders of the stock and which hedge funds were making big moves.


The largest stake in Qiagen NV (NASDAQ:QGEN) was held by AQR Capital Management, which reported holding $81.1 million worth of stock at the end of September. It was followed by D E Shaw with a $60.5 million position. Other investors bullish on the company included Healthcor Management LP, Sandler Capital Management, and Millennium Management.

Since Qiagen NV (NASDAQ:QGEN) has experienced declining sentiment from the smart money, it’s easy to see that there were a few money managers that elected to cut their entire stakes last quarter. It’s worth mentioning that Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital sold off the largest position of the “upper crust” of funds tracked by Insider Monkey, comprising an estimated $30.1 million in stock, and Glenn Russell Dubin’s Highbridge Capital Management was right behind this move, as the fund sold off about $13.1 million worth. These bearish behaviors are interesting, as total hedge fund interest fell by 3 funds last quarter.

Let’s now take a look at hedge fund activity in other stocks – not necessarily in the same industry as Qiagen NV (NASDAQ:QGEN) but similarly valued. These stocks are Avery Dennison Corporation (NYSE:AVY), Brown & Brown, Inc. (NYSE:BRO), EXACT Sciences Corporation (NASDAQ:EXAS), and National Retail Properties, Inc. (NYSE:NNN). This group of stocks’ market caps are closest to QGEN’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
AVY 28 474724 -1
BRO 20 675949 -2
EXAS 30 672423 -3
NNN 15 263404 4
Average 23.25 521625 -0.5

View table here if you experience formatting issues.

As you can see these stocks had an average of 23.25 hedge funds with bullish positions and the average amount invested in these stocks was $522 million. That figure was $361 million in QGEN’s case. EXACT Sciences Corporation (NASDAQ:EXAS) is the most popular stock in this table. On the other hand National Retail Properties, Inc. (NYSE:NNN) is the least popular one with only 15 bullish hedge fund positions. Qiagen NV (NASDAQ:QGEN) is not the least popular stock in this group but hedge fund interest is still below average. Our calculations showed that the top 15 most popular stocks among hedge funds returned 21.3% through April 8th and outperformed the S&P 500 ETF (SPY) by more than 5 percentage points. Hedge funds were also right about betting on QGEN, though not to the same extent, as the stock returned 19.9% and outperformed the market as well.

Disclosure: None. This article was originally published at Insider Monkey.